Skip to main content
Premium Trial:

Request an Annual Quote

Screens Work

Premium

The Centers for Disease Control and Prevention recently said that increased screening for colorectal cancer in the US in the past 10 years has lowered both disease incidence rates and colorectal cancer death rates, says the Los Angeles Times' Thomas Maugh II. In its recent Morbidity and Mortality Weekly Report, the CDC said that the prevalence rate for colorectal cancer fell from 52.3 cases per 100,000 in 2003 to 45.4 per 100,000 in 2007, as screening among adults aged 50 to 75 increased from half of the population to two-thirds. The death rate also fell from 19 per 100,000 to 16.7 100,000 in the same time, Maugh says. There are many people in the 50 to 75 age group who are not being screened, however, and clinicians are being urged to step up efforts to get their patients in for a regular checks, Maugh adds.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.